GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $430,000 | -7.5% | 11,411 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $465,000 | +14.5% | 11,411 | +6.4% | 0.00% | -25.0% |
| Q1 2020 | $406,000 | -26.3% | 10,728 | -8.5% | 0.00% | 0.0% |
| Q4 2019 | $551,000 | +13.1% | 11,730 | +2.8% | 0.00% | 0.0% |
| Q3 2019 | $487,000 | +6.6% | 11,411 | 0.0% | 0.00% | +33.3% |
| Q2 2019 | $457,000 | -4.4% | 11,411 | -0.3% | 0.00% | -25.0% |
| Q1 2019 | $478,000 | -1.4% | 11,441 | -9.8% | 0.00% | -20.0% |
| Q4 2018 | $485,000 | -4.7% | 12,680 | 0.0% | 0.01% | -28.6% |
| Q3 2018 | $509,000 | -0.4% | 12,680 | 0.0% | 0.01% | +40.0% |
| Q2 2018 | $511,000 | -15.4% | 12,680 | -18.0% | 0.01% | -28.6% |
| Q1 2018 | $604,000 | +11.0% | 15,459 | +0.8% | 0.01% | +16.7% |
| Q4 2017 | $544,000 | -12.5% | 15,331 | 0.0% | 0.01% | -14.3% |
| Q3 2017 | $622,000 | -5.9% | 15,331 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $661,000 | -9.6% | 15,331 | -11.5% | 0.01% | 0.0% |
| Q1 2017 | $731,000 | +8.6% | 17,331 | -0.9% | 0.01% | 0.0% |
| Q4 2016 | $673,000 | -9.9% | 17,481 | +0.9% | 0.01% | -11.1% |
| Q3 2016 | $747,000 | -4.7% | 17,331 | -4.2% | 0.01% | -10.0% |
| Q2 2016 | $784,000 | -4.2% | 18,096 | -10.3% | 0.01% | -9.1% |
| Q1 2016 | $818,000 | -18.2% | 20,169 | -18.6% | 0.01% | -21.4% |
| Q4 2015 | $1,000,000 | -21.8% | 24,790 | -25.5% | 0.01% | -22.2% |
| Q3 2015 | $1,279,000 | -13.5% | 33,263 | -6.2% | 0.02% | -10.0% |
| Q2 2015 | $1,478,000 | -17.3% | 35,479 | -8.4% | 0.02% | -16.7% |
| Q1 2015 | $1,788,000 | -5.8% | 38,749 | -12.7% | 0.02% | -11.1% |
| Q4 2014 | $1,898,000 | -31.3% | 44,401 | -26.1% | 0.03% | -34.1% |
| Q3 2014 | $2,763,000 | -95.6% | 60,109 | -94.9% | 0.04% | -95.7% |
| Q2 2014 | $62,994,000 | +30.4% | 1,177,901 | +30.2% | 0.96% | +23.8% |
| Q1 2014 | $48,321,000 | +2.6% | 904,368 | +2.6% | 0.77% | +0.3% |
| Q4 2013 | $47,079,000 | +9.7% | 881,803 | +3.1% | 0.77% | +0.1% |
| Q3 2013 | $42,919,000 | +5.4% | 855,476 | +5.0% | 0.77% | +0.1% |
| Q2 2013 | $40,715,000 | – | 814,787 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JTC Employer Solutions Trustee Ltd | 6,324,319 | $241,621,000 | 32.36% |
| Black Creek Investment Management Inc. | 10,329,349 | $394,684,000 | 11.46% |
| Healthcare Value Capital, LLC | 100,000 | $3,821,000 | 7.54% |
| KAHN BROTHERS GROUP INC | 1,353,358 | $51,711,809,000 | 7.28% |
| EQUITY INVESTMENT CORP | 2,924,326 | $111,738,000 | 4.28% |
| Eversept Partners, LP | 1,503,700 | $57,456,377 | 3.99% |
| NKCFO LLC | 269,500 | $10,298,000 | 3.45% |
| Robinson Value Management, Ltd. | 96,990 | $3,706,000 | 3.31% |
| Keystone Financial Planning, Inc. | 237,691 | $9,082,000 | 3.30% |
| CLIFFORD CAPITAL PARTNERS LLC | 93,485 | $3,572,000 | 3.27% |